Cytokine activation through sublethal hemorrhage is protective against early lethal endotoxic challenge

Archives of Surgery

Volumn 132, Issue 11, 1997, Pages 1216-1221

  Zervos, Emmanuel E ^a   Norman, James G ^a   Denham, Daphne W ^a   Carey, Larry C ^a   Livingston, David ^b   Rosemurgy, Alexander S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLEEDING; CONFERENCE PAPER; CONTROLLED STUDY; LETHALITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SURVIVAL; TRANSGENIC MOUSE;

EID: 0030724398     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430350066011     Document Type: Conference Paper

References (46)

1. Martin MA. Epidemiology and clinical impact of gram-negative sepsis. Infect Dis Clin North Am. 1991;5:739-752.
2. Bone RC. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev. 1993;6:57-68.
3. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992;216:117-134.
4. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
5. Taveira da Silva AM, Kaulbach HC, Chuidian FS. Shock and multiple-organ dysfunction after self-administration of salmonella endotoxin. N Engl J Med. 1993; 328:1457-1460.
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
7. Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990;55:157-170.
8. Ferrari-Baliviera E, Mealy K, Smith RJ, et al. Tumor necrosis factor induces adult respiratory distress syndrome in rats. Arch Surg. 1989;124:1400-1405.
9. Ohlsson K, Bjork P, Bergenfeldt M, et al. An interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990;348:550-552.
10. Wakabayashi G, Gelfand JA, Burke JF, et al. A specific receptor antagonist for interleukin-1 prevents E coli induced shock in rabbits. FASEB J. 1991;5:338-343.
11. Abraham E, Jesmok G, Tuder R, et al. Contribution of tumor necrosis factor-α to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med. 1995;23:1319-1326.
12. Zingarelli B, Squadrito F, Altavilla D, et al. Role of tumor necrosis factor-α in acute hypovolemic hemorrhagic shock in rats. Am J Physiol. 1994;266:H1512-H1515.
13. Remick DG, Colletti LM, Scales WA, et al. Cytokines and extrahepatic sequelae of ischemia-reperfusion injury to the liver. Ann N Y Acad Sci. 1994;723:271-283.
14. Yao YM, Sheng ZY, Tian HM, et al. The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemiareperfusion injury. Resuscitation. 1995;29:157-168.
15. Sekido N, Mukaida N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by a mononuclear antibody against interleukin-8. Nature. 1993;365:654-657.
16. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995:117:648-655.
17. Acton RD, Dahlberg PS, Uknis ME, et al. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors. Arch Surg. 1996;131:1216-1221.
18. Zingarelli B, Halushka PV, Caputi AP, et al. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock. 1995;3:102-108.
19. Hafenfichter DG, Roland CR, Mangino MJ, et al. The Kupffer cell in endotoxin tolerance: mechanisms of protection against lethal endotoxemia. Shock. 1994; 2:251-256.
20. Chen H, Halushka PV, Cook JA. Endotoxin tolerance: effects on lethality and macrophage thrombooxane (B2) and interleukin 6 production. Shock. 1994;1:366-371.
21. Baker CC, Chaudry IH, Gaines HO, et al. Evaluation of factors affecting mortality following sepsis in a murine cecal ligation and puncture model. Surgery. 1983; 94:331-335.
22. Ayala A, Kisala JM, Felt JA, et al. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin-1, interleukin-6, or tumor necrosis factor) during sepsis? Arch Surg. 1992;127:196-197.
23. Baker CC, Niven-Fairchild T, Caragnano C, et al. Outcome following femur fracture and subsequent cecal ligation and puncture in endotoxin-sensitive (C3H/ HeN) and endotoxin resistant (C3H/HeJ) mice. J Surg Res. 1991;50:170-174.
24. Vogels M, Mensink E, Ye K, et al. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1 induced resistance to infection. J Immunol. 1994;153:5772-5780.
25. Keel M, Schregenberger N, Steckholzer U, et al. Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma. 1996;41:430-437.
26. Nakamori T, Sakata Y, Watanabe T, et al. Suppression of interleukin-1 beta production in the circumventricular organs in endotoxin-tolerant rabbits. Brain Res. 1995;675:103-109.
27. Granowitz EV, Porat T, Mier JW, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 1993;151:1637-1645.
28. Erroi A, Fantuzzi G, Mengozzi M, et al. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect Immun. 1993;61:4356-4359.
29. Kuda K, Lippke J, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 converting enzyme. Science. 1995;267:2000-2003.
30. Norman J, Fink G, Carter G, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg. 1996;223:163-169.
31. Norman J, Yang J, Fink G, et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine fies. 1997;17:113-118.
32. Leon P, Redmond HP, Shou J, et al. Interleukin-1 and its relationship to endotoxin. Arch Surg. 1992;127:146-151.
33. Roth J, McClellan JL, Kluger MJ, et al. Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs. J Physiol. 1994;477:177-185.
34. Wakabayashi G, Cannon JG, Gelfand JA, et al. Altered interleukin-1 and tumor necrosis factor production and secretion during pyrogenic tolerance to LPS in rabbits. Am J Physiol. 1994;267:R329-R336.
35. Chaudry IH, Ayala A, Ertel W, et al. Hemorrhage and resuscitation: immunological aspects. Am J Physiol. 1990;259:R663-R678.
36. Zervos E, Norman J, Carey L, et al. Sublethal hemorrhage blunts the inflammatory cytokine response to sepsis in a rat model. J Trauma. In press.
37. Wilson JD, Stewart RM, Fabian TC, et al. Plasma tumor necrosis factor and post-traumatic hyperdynamic sepsis evoked by endotoxin. Shock. 1994;1:176-183.
38. Geisel J, Cook JA, Ashton SH, et al. Endotoxin tolerance is associated with decreased prostaglandin H synthases-1 and -2. Am J Physiol. 1994;267:C1067-C1072.
39. Sironi M, Bianchi M, Riganti F, et al. Suppression of interleukin-6 production in endotoxin tolerance in a mouse glioma cell line: reversal by phorbol ester. Lymphokine Cytokine Res. 1993;12:39-43.
40. Deitch EA, Specian RD, Berg RD. Induction of early-phase tolerance to endotoxin-induced mucosal injury, xanthine oxidase activation, and bacterial translocation by pretreatment with endotoxin. Circ Shock. 1992;36:208-216.
41. Zuckerman SH, Evans GF. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol. 1992;140:513-519.
42. McCall CE, Grosso-Wilmouth LM, LaRue K, et al. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest. 1993;91:853-861.
43. Ertel W, Morrison MH, Ayala A, et al. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol. 1995; 269:R160-R166.
44. Fabian TC, Croce MA, Fabian MJ, et al. Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: experimental results and clinical correlation. Surgery. 1995;118:63-72.
45. Rush BF. The bacterial factor in hemorrhagic shock. Surg Gynecol Obstet. 1992; 175:285-292.
46. Bahrami S, Schlag G, Yao Y, et al. Significance of translocation/endotoxin in the development of systemic sepsis following trauma and/or hemorrhage. Prog Clin Biol Res. 1995;392:197-208.